Want to join the conversation?
$CERN's earnings for 2015 grew from last year. The rise was primarily a result of increased revenues, partially offset by elevated operating expenses, which included costs associated with the acquisition and integration of the $CERN Health Services business, and its voluntary separation plan.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.